MeiraGTx Holdings plc SEC filings MGTX
MeiraGTx Holdings plc has 509 filings in SEC EDGAR's recent list, going back to Mar 29, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 23, 2026 | Sep 22, 2026 |
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Regulation FD disclosure
|
Jul 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 11, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Material agreement
|
Apr 24, 2026 | Apr 20, 2026 |
| 424B5 | Prospectus supplement | Apr 16, 2026 | — |
| 8-K |
Current report
Material agreement
|
Apr 16, 2026 | Apr 16, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Apr 16, 2026 | Apr 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 16, 2026 | Apr 16, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Results of operations, New debt
|
Mar 26, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Material agreement
|
Jan 2, 2026 | Dec 31, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 10, 2025 | Nov 7, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2025 | Jun 12, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 9, 2025 | May 9, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Apr 4, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Mar 13, 2025 | Mar 9, 2025 |
| 8-K |
Current report
Other events
|
Dec 9, 2024 | Dec 9, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Other events
|
Aug 13, 2024 | Aug 12, 2024 |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 6, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 6, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 16, 2024 | Apr 25, 2022 |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Other events
|
Feb 13, 2024 | Feb 13, 2024 |
| EFFECT | Filing | Dec 29, 2023 | — |
| CORRESP | Letter to the SEC | Dec 27, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 27, 2023 | — |
| S-3 | Shelf registration | Dec 21, 2023 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, New debt, Regulation FD disclosure
|
Dec 21, 2023 | Dec 20, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 30, 2023 | Oct 30, 2023 |
| EFFECT | Filing | Aug 11, 2023 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Results of operations, New debt
|
Aug 10, 2023 | Aug 10, 2023 |
| CORRESP | Letter to the SEC | Aug 9, 2023 | — |
| CORRESP | Letter to the SEC | Aug 9, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| S-3 | Shelf registration | Aug 3, 2023 | — |
| S-3 | Shelf registration | Aug 3, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2023 | Jun 8, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 9, 2023 | May 3, 2023 |
| UPLOAD | Letter from the SEC | May 4, 2023 | — |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 8, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2023 | Apr 21, 2023 |
| CORRESP | Letter to the SEC | Apr 24, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 13, 2023 | — |
| 10-K | Annual report | Mar 14, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2023 | Mar 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| DEFA14A | Additional proxy material | Jan 20, 2023 | — |
| DEF 14A | Proxy statement | Dec 23, 2022 | Jan 24, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Nov 10, 2022 | Nov 9, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Aug 4, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2022 | Jun 27, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 7, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 27, 2022 | Apr 25, 2022 |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| CT ORDER | Filing | Mar 8, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 7, 2021 | Dec 7, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 10-Q | Quarterly report | Aug 11, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| S-8 | Employee stock plan registration | Jun 17, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2021 | Jun 10, 2021 |
| 10-Q | Quarterly report | May 11, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 10, 2021 |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2021 | Mar 11, 2021 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 17, 2020 | Dec 16, 2020 |
| 8-K |
Current report
Other events
|
Nov 23, 2020 | Nov 19, 2020 |
| 424B5 | Prospectus supplement | Nov 19, 2020 | — |
| 424B5 | Prospectus supplement | Nov 18, 2020 | — |
| 8-K |
Current report
Agreement ended
|
Nov 18, 2020 | Nov 18, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 16, 2020 | Nov 13, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 6, 2020 | Oct 3, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 17, 2020 | Jul 17, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2020 | Jun 2, 2020 |
| DEFA14A | Additional proxy material | May 26, 2020 | — |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations
|
May 7, 2020 | May 7, 2020 |
| DEFA14A | Additional proxy material | Apr 21, 2020 | — |
| DEF 14A | Proxy statement | Apr 21, 2020 | Jun 2, 2020 |
| 10-K | Annual report | Mar 11, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2020 | Mar 11, 2020 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 31, 2019 | Feb 19, 2019 |
| 10-Q | Quarterly report | Nov 7, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2019 | Nov 7, 2019 |
| 8-K |
Current report
Other events
|
Aug 9, 2019 | Aug 7, 2019 |
| 424B5 | Prospectus supplement | Aug 9, 2019 | — |
| 424B5 | Prospectus supplement | Aug 7, 2019 | — |
| 8-K |
Current report
Results of operations
|
Aug 7, 2019 | Aug 7, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
| EFFECT | Filing | Jul 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2019 | — |
| CORRESP | Letter to the SEC | Jul 18, 2019 | — |
| S-3 | Shelf registration | Jul 17, 2019 | — |
| EFFECT | Filing | Jul 16, 2019 | — |
| CORRESP | Letter to the SEC | Jul 12, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 9, 2019 | — |
| S-3 | Shelf registration | Jul 2, 2019 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2019 | Jun 3, 2019 |
| 8-K |
Current report
Results of operations
|
May 15, 2019 | May 14, 2019 |
| 10-Q | Quarterly report | May 14, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 10, 2019 | May 9, 2019 |
| CT ORDER | Filing | May 9, 2019 | — |
| DEFA14A | Additional proxy material | Apr 29, 2019 | — |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2019 | Apr 16, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 12, 2019 | Jun 19, 2019 |
| 10-K | Annual report | Mar 26, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2019 | Mar 26, 2019 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Mar 4, 2019 | Feb 26, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 27, 2019 | Feb 27, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 22, 2019 | Feb 19, 2019 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 5, 2019 | Jan 30, 2019 |
| 8-K |
Current report
Material agreement
|
Feb 4, 2019 | Jan 29, 2019 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Dec 20, 2018 | Dec 14, 2018 |
| 10-Q | Quarterly report | Nov 8, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2018 | Nov 8, 2018 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2018 | Oct 2, 2018 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Oct 9, 2018 | Oct 5, 2018 |
| 10-Q | Quarterly report | Aug 8, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2018 | Aug 8, 2018 |
| S-8 | Employee stock plan registration | Jun 8, 2018 | — |
| 424B4 | Prospectus | Jun 8, 2018 | — |
| CERT | Filing | Jun 8, 2018 | — |
| 8-A12B | Filing | Jun 8, 2018 | — |
| CT ORDER | Filing | Jun 8, 2018 | — |
| EFFECT | Filing | Jun 7, 2018 | — |
| CORRESP | Letter to the SEC | Jun 5, 2018 | — |
| CORRESP | Letter to the SEC | Jun 5, 2018 | — |
| FWP | Free writing prospectus | Jun 4, 2018 | — |
| S-1/A | Amended registration statement | Jun 4, 2018 | — |
| S-1/A | Amended registration statement | May 29, 2018 | — |
| S-1/A | Amended registration statement | May 23, 2018 | — |
| UPLOAD | Letter from the SEC | May 22, 2018 | — |
| CORRESP | Letter to the SEC | May 21, 2018 | — |
| S-1 | Registration statement | May 14, 2018 | — |
| DRSLTR | Filing | May 11, 2018 | — |
| DRS/A | Filing | May 11, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2018 | — |
| DRS/A | Filing | Apr 13, 2018 | — |
| DRS | Filing | Mar 29, 2018 | — |
Showing 195 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- MGTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1735438
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.